Treating Pulmonary Hypertension in COPD without right heart catheterization, an investigation mostly not feasible in developing world.

Not Applicable

Conditions: Health Condition 1: null- COPD with pulmonary hypertension

Registration Number: CTRI/2015/07/005962

Lead Sponsor: Institute of Pulmocare and Research

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 100

Inclusion Criteria

a) These patients shall have to be on optimal standard mamagement of COPD and existing co-morbid conditions.(The management of COPD should include standard pharmacotherapy as per guideline, logistically best possible education and training for self managed rehabilitation and home oxygen therapy as and when indicated).

b) A proper written informed consent will be taken before including the patients in the study.

Exclusion Criteria

a) Patients unwilling to give proper written informed consent.

b) Patients with severe co-morbid states affecting the quality of life.

c) Very advanced COPD with inability to follow up or perform spirometry.

d) History of exacerbation in the preceding six weeks.

e) Patients with suspected OSA, ILD, left heart disease and pulmonary embolism (radiological suspicion for ILD, clinical suspicion of OSA from snoring, high BMI, excessive day time somnolence, observed apneas, and / or other features suggesting SDB).

f) Patients with clinico-radio-echocardiographic suggestions of pulmonary embolism and echocardiography showing the presence of any significant left heart disease.

g) Patients with known intolerance of sildenafil

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
a) To define PH in COPD patients on a composite clinico-radio-echocardiographic method. <br/ ><br>b) To look for the change in the quality of life through the use of CAT (COPD assessment test)scoring.Timepoint: Nil

Secondary Outcome Measures